Caricamento...
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase
Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. Although rodent studies suggested potential effects of ACL inhibition on both fatty acid and...
Salvato in:
| Pubblicato in: | Curr Atheroscler Rep |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035316/ https://ncbi.nlm.nih.gov/pubmed/27663902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-016-0611-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|